I watched the camaraderie and family-like atmosphere from the periphery.
Despite being a wallflower, that first meeting had a huge impact on me. The content excited me. I had never attended a meeting before where I listened to every talk in every session. I was exposed to the different academic programs in our field around the country, and I was inspired by the Society's accomplishments and lofty goals from then President, Michael Jaff.
I remember hearing Jerry Bartholomew's update on venous thromboembolism and laughing as he started his talk with a story about previously taking a train to California from Cleveland due to a long-standing fear of flying (one which I shared and that we both have largely overcome). In that brief exposure, I was struck by Jerry's special combination of medical knowledge, humanity, and self-deprecating humor. When the opportunity came to join his group in Cleveland a few months later, I knew he would be an inspiring boss … and suspected he may ultimately become a dear friend.
Since my first SVM meeting in Anaheim in 2004 and my second meeting in Chicago in 2005 (for the first-ever Board Review Course), I have attended every SVM meeting and have become more and more involved in our organization. I thank President John Cooke who was the first to engage me in SVM leadership when he asked me to cochair the Advocacy Committee. I was in over my head, but I was eager to do my best for SVM and get to work.
In subsequent years, I've had many roles in the SVM, culminating in my tenure on our Board of Trustees and standing before you today as President. As you know, I have also had the honor of serving as Editor-in-Chief of Vascular Medicine since 2014. Throughout, I have made lifelong friends, developed meaningful professional collaborations with those senior and junior to me, and honed new skills (journal editing, lobbying Congressional staffers with dear departed friends Alan Hirsch and Emile Mohler, and meeting planning to name a few). I've learned about every sort of vascular disease -from the mundane to the spotted zebra, PAD to FMD, and everything in between. All the while, I have been grateful for a chance to contribute to our field and do my small part to try to help battle the global scourge of vascular disease. It has been a tremendous 15 years in this organization.
For those of you here today at your first SVM meeting, as well as those members of our Next Generation Committee here with us today, I hope that you too may someday reflect on that fabulous Chicago SVM meeting of 2018 and how it was the beginning of your own journey in our Society.
Indeed, in June 2033, one of you will be standing in my place giving the Presidential Address! This past year as SVM President has been a professional dream come true. Leading this wonderful organization and engaging with our members on a daily basis has been a joyous assignment. We have had a busy year, and as I share with you some of our accomplishments in the next few minutes, I hope you will agree that the foundation of our Society is strong.
During the past year, the Board of Trustees, with the help of the Bylaws, Policies, and Procedures Committee (under the enthusiastic leadership of Peter Angelopoulos) has focused on strengthening our foundation by revisiting our governance. We updated our mission statement for the 21st century, and we even created a tagline:
Promoting and advancing the discipline of vascular medicine and the care of patients with vascular disease.
We have broadened our membership categories and extended voting privileges to all doctoral and advanced practice members in addition to fellows. And this morning, we voted on the first update of our bylaws since 2010. More importantly, we have reinvigorated the committee structure of our Society, engaging more members than ever in our activities. My tremendous thanks to all of the committee chairs and all of their committee members who have helped us plan this year's events and new programs for the years to come. I particularly want to acknowledge our PresidentElect and my friend Raghu Kolluri for his work and that of his committee in planning this tremendous, innovative meeting. Truly the best one yet and delivered seemingly effortlessly. Thank you, Raghu.
The Board of Trustees and our committees have been hard at work developing programming that adds value to your SVM membership. The focus of the past year has been on educational programs, including those for current SVM members and vascular trainees, as well as the general medical community and even patients with vascular disease.
Our journal, Vascular Medicine, continues to serve as a primary educational tool for our Society through our Core Curriculum in Vascular Medicine series, CME review articles, and Vascular Disease Patient Information Pages. And while I have focused most of my efforts on our journal, other SVM leaders have worked to develop live and online educational programs in the past year.
As of a few days ago, the 2018 edition of the SVM Board Review Course is now available online for those preparing for their ABVM certification or recertification exams. Thanks to the Education Committee, and especially to Greg Piazza and Aditya Sharma for bringing this to fruition.
Last December, under the leadership of Raghu Kolluri, Mehdi Shishehbor, and Ido Weinberg, SVM rolled out its first stand-alone Fellows Course. The program brought 51 fellows from different disciplines to Atlanta to learn vascular medicine from a faculty of SVM master educators. This was a wildly successful event, and I suggest that each of you either apply to attend or refer fellows to apply for the 2018 course.
Focusing on vascular education of front-line medical providers, including emergency and family medicine physicians, we have partnered with Janssen Pharmaceuticals to develop an online toolkit for pulmonary embolism (PE). The toolkit emphasizes risk stratification and appropriate patient selection for outpatient management of low-risk PE. The program also includes a portal of patient information. Thanks to Jerry Bartholomew and his committee for this program, which is now freely available at: mypulmonaryembolism.com. Owing to the success of the PE toolkit and our prior DVT toolkit, SVM will continue its partnership with Janssen Pharmaceuticals in 2018 to develop a state-ofthe-art toolkit for management of patients with peripheral artery disease. This project is being led by Jay Bishop and Elizabeth Ratchford and will roll out later this year.
Beyond educational programming, we have worked hard to build community and fellowship among our members. The Next Generation Committee, a reboot of our early career committee, is led by Christina Fanola and Yogen Kanthi and has given a blast of energy to SVM. The committee held its first networking event concurrent with the ACC Scientific Sessions in March 2018 and promises more to come. Members have infiltrated almost all of our committees, bringing fresh ideas, enthusiasm, and some millennial sensibilities. They have disseminated knowledge, love of SVM, and good humor through Twitter using the hashtag #SVMNextGen. They are the future of our Society, and based upon their initial efforts, I know we will be in good hands.
I would also like to spotlight our new Taskforce on Vascular Medicine Practice, chaired by Jay Bishop. This committee is focused on developing programming that is of value to our members who have a clinical focus. I am particularly excited to announce that the Taskforce is working to develop the 2018 Vascular Medicine Clinical Practice and Compensation Survey. Stay tuned for information regarding this effort later this year and please participate, when asked, to be sure that the data collected reflect the diversity of our specialty and our practice environments.
Finally, we have worked this year to build upon existing SVM organizational partnerships. We have formalized a collaborative relationship with VAS: European Angiology/ Vascular Medicine and have continued existing collaborations with more than a dozen other cardiovascular organizations. Most importantly, we have strengthened our communication and collaboration with the American Board of Vascular Medicine (ABVM), and I thank Bruce Gray, Chief Operating Officer of the ABVM, for his partnership.
I want to take a moment to acknowledge our staff from Kellan Company, without whom none of these programs would have come to fruition. Annie Cox, Administrative Director; Kim Santos, Meetings Manager; Justin Dreyfus, Communications Manager; and Tonya Cabrera, Exhibitor Liaison, have worked hard on behalf of SVM throughout the year. I want to give personal thanks to our Executive Director, Leslie Monahan, who has been a true partner and friend to me and our Trustees this past year. Leslie, I hope SVM gets to work with you for many years to come.
Developing new programs is the fun part of running an organization, but no new programs are possible without a strong financial foundation. I am pleased to report that our assets have increased each year since 2011 (Figure 1) , and we were able to move reserve funds to investment accounts earlier this year. Though our current financial stability reflects the effort of many of our leaders, I acknowledge our past and current treasurers, Jim Froehlich (also a Past-President), Raghu Kolluri, and Ido Weinberg, for their cautious stewardship of our treasury. I would also like to thank Past-President Michael Bacharach for his truly tireless fundraising efforts on behalf of SVM.
Though I would like to be able to report similar improvements in our membership, I cannot. Despite some effort, our membership numbers have been stable during recent years (Figure 2 ), but we have seen little growth. During his presidency from 2011 to 2013, Josh Beckman gave our Trustees a goal of growth to 1000 SVM members over the next 10 years. Unfortunately, in 2018, we remain far from that goal, with just over 500 members. Now that our finances are in order, growing our membership will be a primary objective of our Board for the coming year. Our vote this morning to broaden membership categories and privileges will hopefully facilitate this effort. Herb Aronow and Peter Angelopoulous and their Membership Committee met on Wednesday afternoon to discuss novel strategies to grow our ranks. I am eager to see these plans implemented prior to next year's Scientific Sessions.
As I close, I encourage each of you to reflect on your own engagement in our Society. A small Society such as ours will thrive or perish based on the engagement of its members. We need all of you to fully engage with us and advance our mission.
Beyond paying your dues, how can you join in and help us grow? Here are some ideas: SVM is a tight-knit vascular community. We are connected through our training programs, through our clinical pursuits and research, and even through Twitter. I consider our Society to be my professional family. A family of like-minded yet diverse professionals who are passionate about vascular medicine, vascular research, and patient care.
A family where Esther Kim of Vanderbilt University is the academic descendant of Jay Coffman of Boston University, and Ana Casanegra of Mayo Clinic is the academic descendent of Jess Young of Cleveland Clinic.
A family that learns, laughs, and debates (and sometimes argues). A family that has been a great source of support for me through times of struggle.
Enjoy this year's homecoming with our SVM family, and may there be many, many more in the years to come.
